Serge Paul Eholié is a professor of Tropical and Infectious Diseases in the Medical School of University Félix Houphouet-Boigny, Abidjan, Côte d’Ivoire; He also works as a Medical Doctor in the Unit of Infectious Disease, Treichville University Teaching Hospital, Abidjan, Côte d’Ivoire, and is President of African Network for HIV Practitioners on HIV/AIDS (ANEPA), Vice-President of Alliance Francophone des Acteurs de Santé contre le VIH (AFRAVIH) and Coordinator of steering committee of therapeutic handbook for HIV in Africa.
Furthermore, Dr. Eholié is a Member of the Guidelines developing Group of HIV WHO guidelines 2013. Dr. Ehilié is Principal Investigator of the ANRS 12136-Temprano Study. Early antiretroviral therapy, Principal Investigator of ANRS 12 269-THILAO Study (Third Line Antiretroviral Optimization). Third line trial in sub-Saharan countries (Côte d’Ivoire, Burkina-Faso, Cameroun, Mali, Sénégal) and Principal Investigator of ANRS_HIV-2 First line trial in West Africa (Côte d’Ivoire, Burkina-Faso, Guinée, Sénégal, Togo)